These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 9369955)
41. [Morphologic and hist-enzymatic aspects of palmar aponeurosis in a patient with Marfan syndrome associated with Dupuytren's contracture]. Montagnani S; Passaretti U; Fusco M Arch Putti Chir Organi Mov; 1989; 37(2):355-62. PubMed ID: 2624543 [TBL] [Abstract][Full Text] [Related]
42. [The role of myofibroblasts in the pathogenesis of Dupuytren's contracture]. Salamon A; Hámori J Handchirurgie; 1980; 12(1-2):113-7. PubMed ID: 7195866 [TBL] [Abstract][Full Text] [Related]
43. The effect of interferon-alpha2b on an in vitro model Dupuytren's contracture. Sanders JL; Dodd C; Ghahary A; Scott PG; Tredget EE J Hand Surg Am; 1999 May; 24(3):578-85. PubMed ID: 10357539 [TBL] [Abstract][Full Text] [Related]
45. Biochemical studies on the collagen of the palmar aponeurosis affected with Dupuytren's disease. Hanyu T; Tajima T; Takagi T; Sasaki S; Fujimoto D; Isemura M; Yosizawa Z Tohoku J Exp Med; 1984 Apr; 142(4):437-43. PubMed ID: 6740656 [TBL] [Abstract][Full Text] [Related]
46. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy? Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022 [TBL] [Abstract][Full Text] [Related]
47. [Investigations regarding the pathogenesis of fibromatosis of the palmar fascia (Dupuytren's contracture) (author's transl)]. Sonntag W; Paulini K Z Orthop Ihre Grenzgeb; 1976 Oct; 114(5):764-8. PubMed ID: 997730 [TBL] [Abstract][Full Text] [Related]
48. Alpha 2 beta 1 integrin mediates dermal fibroblast attachment to type VII collagen via a 158-amino-acid segment of the NC1 domain. Chen M; O'Toole EA; Li YY; Woodley DT Exp Cell Res; 1999 Jun; 249(2):231-9. PubMed ID: 10366422 [TBL] [Abstract][Full Text] [Related]
49. RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease. Riester SM; Arsoy D; Camilleri ET; Dudakovic A; Paradise CR; Evans JM; Torres-Mora J; Rizzo M; Kloen P; Julio MK; van Wijnen AJ; Kakar S BMC Med Genomics; 2015 Oct; 8():59. PubMed ID: 26446724 [TBL] [Abstract][Full Text] [Related]
50. Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2. Tse R; Howard J; Wu Y; Gan BS BMC Musculoskelet Disord; 2004 Nov; 5(1):41. PubMed ID: 15541177 [TBL] [Abstract][Full Text] [Related]
51. Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts. Wong M; Mudera V J Hand Surg Br; 2006 Oct; 31(5):473-83. PubMed ID: 16875762 [TBL] [Abstract][Full Text] [Related]
52. Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic rat. Satish L; Palmer B; Liu F; Papatheodorou L; Rigatti L; Baratz ME; Kathju S BMC Musculoskelet Disord; 2015 Jun; 16():138. PubMed ID: 26049932 [TBL] [Abstract][Full Text] [Related]
53. The myofibroblast in Dupuytren's contracture. Rudolph R; Vande Berg J Hand Clin; 1991 Nov; 7(4):683-92; discussion 693-4. PubMed ID: 1769990 [TBL] [Abstract][Full Text] [Related]
54. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease. Ulrich D; Hrynyschyn K; Pallua N Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511 [TBL] [Abstract][Full Text] [Related]
55. Immunopathological study on palmar aponeurosis in Dupuytren's disease. Józsa L; Demel S; Pintér T; Renner A; Réffy A; Sántha A; Salamon A Acta Histochem; 1988; 83(2):153-8. PubMed ID: 3138883 [TBL] [Abstract][Full Text] [Related]
56. Increased metabolic activity of fibroblasts derived from cords compared with nodule fibroblasts sampling from patients with Dupuytren's contracture. Seyhan H; Kopp J; Schultze-Mosgau S; Horch RE Plast Reconstr Surg; 2006 Apr; 117(4):1248-52. PubMed ID: 16582795 [TBL] [Abstract][Full Text] [Related]
57. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease. Ulrich D; Ulrich F; Piatkowski A; Pallua N Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795 [TBL] [Abstract][Full Text] [Related]
58. Cytokine manipulation of explanted Dupuytren's affected human palmar fascia. Kuhn MA; Payne WG; Kierney PC; Pu LL; Smith PD; Siegler K; Ko F; Wang X; Robson MC Int J Surg Investig; 2001; 2(6):443-56. PubMed ID: 12678125 [TBL] [Abstract][Full Text] [Related]
59. Dupuytren's contracture; increased cellularity--proliferation, is there equality? Forsman M; Kallioinen L; Kallioinen M; Ryhänen J Scand J Surg; 2005; 94(1):71-5. PubMed ID: 15865122 [TBL] [Abstract][Full Text] [Related]
60. Adiponectin inhibits fibrosis of the palmar aponeurosis in Dupuytren's contracture in male patients. Yamanaka Y; Tajima T; Tsujimura Y; Naito T; Mano Y; Tsukamoto M; Zenke Y; Sakai A Bone Joint Res; 2023 Aug; 12(8):486-493. PubMed ID: 37536684 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]